-
公开(公告)号:PH25937A
公开(公告)日:1991-12-19
申请号:PH38226
申请日:1989-02-21
Applicant: HOECHST AG
Inventor: CRAUSE PETER , HABERMANN PAUL , TRIPIER DOMINIQUE
-
公开(公告)号:NZ229401A
公开(公告)日:1991-10-25
申请号:NZ22940189
申请日:1989-06-02
Applicant: HOECHST AG
Inventor: BONIN WERNER , HABERMANN PAUL , TRIPIER DOMINIQUE , WOEHNER ELISABET
IPC: A61K38/55 , A61K35/56 , A61K38/00 , A61P7/02 , C07K1/14 , C07K1/16 , C07K14/00 , C07K14/435 , C07K14/44 , C07K14/81 , C07K15/08 , A61K37/02
Abstract: The invention relates to a new active substance-amblyommin-for anticoagulant therapy and to a process for the isolation thereof from hard ticks. The isolated protein having a thrombin-inhibitory action has a molecular weight of 20000 to 30000 dalton, an isoelectric point between 5.05 and 5.65 and the partial amino acid sequences Ile-Leu-Phe-Thr-Gln-Gly-Asn-X-Gly-Glu-Leu-Glu-Asn-X-Phe-Glu-, Lys-Ile-Leu-Phe-X-Gln-Gly- and Ala-Ser-Tyr-Ile-Val-X-Ser-Glu-Ser-Ile-Gln-Ile-Leu-X-Leu-Ser-Glu-Gly-Ile- in which each radical X can be identical or different and each represents a naturally occurring amino acid.
-
公开(公告)号:ZA898553B
公开(公告)日:1990-08-29
申请号:ZA898553
申请日:1989-11-09
Applicant: HOECHST AG
Inventor: HUCHO FERDINAND , FERDINAND HUCHO , PRIBILLA IRIS , IRIS PRIBILLA , SCHIEBLER WERNER , WERNER SCHIEBLER , TRIPIER DOMINIQUE , DOMINIQUE TRIPIER , KOGLER HERBERT , HERBERT KOGLER
IPC: A61K31/195 , A61K31/19 , A61P9/00 , A61P25/00 , A61P29/00 , A61P31/12 , A61P35/00 , A61P43/00 , C07C229/16 , C07K , A61K
Abstract: The present invention relates to the use of EDTA or its analogues as inhibitors of calcium/calmodulin-dependent protein kinase II or of protein kinase C.
-
公开(公告)号:NO163959C
公开(公告)日:1990-08-15
申请号:NO832904
申请日:1983-08-12
Applicant: HOECHST AG
Inventor: SEIPKE GERHARD , TRIPIER DOMINIQUE , JOHNSCHER GERD
IPC: A61K35/26 , A61K38/00 , A61K38/22 , A61P37/00 , C07K1/113 , C07K1/20 , C07K7/04 , C07K14/435 , C07K14/47 , C07K14/575 , C07K15/06
Abstract: The invention relates to a polypeptide which can be isolated from thymus glands and has an action on the immunological system, and which has a molecular weight of 3,480, a UV absorption with a maximum at 205 to 210 nm and an isoelectric point of 3.95+0.15 and a specific aminoacid composition, the N-terminal, if appropriate, carrying an acyl group or an acylglycyl group, processes for its isolation and purification, its use, agents containing this polypeptide, and its cleavage products, their use and agents containing them.
-
公开(公告)号:ZA894179B
公开(公告)日:1990-02-28
申请号:ZA894179
申请日:1989-06-02
Applicant: HOECHST AG
Inventor: SCHULZ ARNO , ARNO SCHULZ , BARTSCH KLAUS , KLAUS BARTSCH , TRIPIER DOMINIQUE , DOMINIQUE TRIPIER , SAUBER KLAUS , KLAUS SAUBER
Abstract: Transaminase, the preparation thereof and the use thereof. A transaminase can be isolated from E. coli DH-1 and can be used with great efficiency to prepare L-phosphinothricin and gamma -aminobutyric acid from the appropriate precursor by transfer of the amino group from glutamate.
-
公开(公告)号:ZA8904181B
公开(公告)日:1990-02-28
申请号:ZA8904181
申请日:1989-06-02
Applicant: HOECHST AG
Inventor: BONIN WERNER , HABERMANN PAUL , TRIPIER DOMINIQUE , WOEHNER ELISABET
IPC: A61K38/55 , A61K35/56 , A61K38/00 , A61P7/02 , C07K1/14 , C07K1/16 , C07K14/00 , C07K14/435 , C07K14/44 , C07K14/81 , C07K , A61K
CPC classification number: C07K14/43527 , A61K35/646 , A61K38/00 , C07K14/811 , Y10S530/855
-
公开(公告)号:PT85443B
公开(公告)日:1989-12-07
申请号:PT8544387
申请日:1987-07-29
Applicant: HOECHST AG
Inventor: KUETTNER KLAUS E , DIMUZIO MICHAEL T , BROCKS DIETRICH , TRIPIER DOMINIQUE
IPC: A61K38/55 , A61K38/00 , A61P7/02 , A61P9/10 , A61P11/00 , A61P13/02 , A61P15/00 , A61P17/00 , A61P29/00 , A61P35/00 , A61P35/02 , C07K14/00 , C07K14/81 , C12N9/99 , C12P21/06 , C07K7/08 , C07K7/10 , C07K3/28 , C07K15/00
Abstract: A protein or a pharmaceutically acceptable salt thereof. The protein has a molecular weight of 10,000-30,000 Dalton, an isoelectric point greater than 9.5, and an N terminus of the sequence H-Lys-X-Phe-Lys-Val-Asp-Val-Leu-Ala-Ala-Leu-X-Phe-Asn-Ala-, wherein X is an amino acid or a tryptic cleavage product which has the sequence -Gly-Ala-Asn-Ala-Val-Asn-. Methods for the isolation and purification of the protein, compositions containing the protein, and methods for the use of the protein and compositions, are also disclosed.
-
公开(公告)号:DE3819079A1
公开(公告)日:1989-12-07
申请号:DE3819079
申请日:1988-06-04
Applicant: HOECHST AG
Inventor: CRAUSE PETER , HABERMANN PAUL , KRAMER MARTIN , OBERMEIER RAINER , SAUBER KLAUS , TRIPIER DOMINIQUE
IPC: C12N9/99 , A61K38/00 , A61K38/55 , A61K47/00 , A61K47/48 , A61P7/02 , C07K1/113 , C07K1/20 , C07K1/22 , C07K14/81 , C07K14/815 , C07K17/10 , C12P21/02 , C12R1/645
Abstract: The present invention relates to hirudin derivatives which are formed from hirudin or its physiologically acceptable salt and of a carrier, to a process for the preparation thereof and to the use thereof as thrombin inhibitor.
-
公开(公告)号:AU3595489A
公开(公告)日:1989-12-07
申请号:AU3595489
申请日:1989-06-01
Applicant: HOECHST AG
Inventor: BONIN WERNER , HABERMANN PAUL , TRIPIER DOMINIQUE , WOEHNER ELISABET
IPC: A61K38/55 , A61K35/56 , A61K38/00 , A61P7/02 , C07K1/14 , C07K1/16 , C07K14/00 , C07K14/435 , C07K14/44 , C07K14/81 , C07K15/12 , C07K15/02 , C12N9/68 , A61K37/02
Abstract: The invention relates to a new active substance-amblyommin-for anticoagulant therapy and to a process for the isolation thereof from hard ticks. The isolated protein having a thrombin-inhibitory action has a molecular weight of 20000 to 30000 dalton, an isoelectric point between 5.05 and 5.65 and the partial amino acid sequences Ile-Leu-Phe-Thr-Gln-Gly-Asn-X-Gly-Glu-Leu-Glu-Asn-X-Phe-Glu-, Lys-Ile-Leu-Phe-X-Gln-Gly- and Ala-Ser-Tyr-Ile-Val-X-Ser-Glu-Ser-Ile-Gln-Ile-Leu-X-Leu-Ser-Glu-Gly-Ile- in which each radical X can be identical or different and each represents a naturally occurring amino acid.
-
公开(公告)号:FI892690A
公开(公告)日:1989-12-05
申请号:FI892690
申请日:1989-06-01
Applicant: HOECHST AG
Inventor: BONIN WERNER , HABERMANN PAUL , TRIPIER DOMINIQUE , WOEHNER ELISABET
IPC: A61K38/55 , A61K35/56 , A61K38/00 , A61P7/02 , C07K1/14 , C07K1/16 , C07K14/00 , C07K14/435 , C07K14/44 , C07K14/81 , A61K
Abstract: The invention relates to a new active substance-amblyommin-for anticoagulant therapy and to a process for the isolation thereof from hard ticks. The isolated protein having a thrombin-inhibitory action has a molecular weight of 20000 to 30000 dalton, an isoelectric point between 5.05 and 5.65 and the partial amino acid sequences Ile-Leu-Phe-Thr-Gln-Gly-Asn-X-Gly-Glu-Leu-Glu-Asn-X-Phe-Glu-, Lys-Ile-Leu-Phe-X-Gln-Gly- and Ala-Ser-Tyr-Ile-Val-X-Ser-Glu-Ser-Ile-Gln-Ile-Leu-X-Leu-Ser-Glu-Gly-Ile- in which each radical X can be identical or different and each represents a naturally occurring amino acid.
-
-
-
-
-
-
-
-
-